FDA safety surveillance data show HORRIFIC adverse events after COVID-19 injections

Print Friendly, PDF & Email

horrific-adverse-events(NaturalHealth365)  Have pharmaceutical, government, and public health officials, including the U.S. Food and Drug Administration (FDA), not been forthcoming about possible adverse events caused by the controversial COVID shot?

If you happened to watch a presentation last year from the FDA’s Center for Biologics Evaluation and Research (CBER), you might find it hard not to believe.

BLINK AND YOU’LL MISS IT:  FDA presentation completely glosses over harrowing side effects suspected from COVID jab

On October 22, 2020, Steve Anderson, the Director, Office of Biostatistics & Epidemiology at CBER, gave a presentation at the Vaccines and Related Biological Products Advisory Committee meeting.  The nearly nine-hour presentation, discussing FDA vaccine surveillance measures as well as the “general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19,” is currently available on YouTube.  (Comments on the video have been disabled.)

We’ve embedded the video here for your viewing – and we encourage you to go ahead and skip to the 2:33:40 mark in the video.

Notice anything unusual?

SHOCKING PROBIOTICS UPDATE: Discover the True Value of Probiotics and How to Dramatically Improve Your Physical, Mental and Emotional Wellbeing with ONE Easy Lifestyle Habit.

The speed with which the precentor clicked through this particular slide is extremely strange – especially when you stop to consider what was on it.

Called a “working list of possible adverse event outcomes” that are subject to change, the slide details a frightening who’s who of negative outcomes that could arise due to the COVID injection. These include:

  • Guillain-Barré syndrome
  • Acute disseminated encephalomyelitis
  • Transverse myelitis
  • Encephalitis/myelitis/encephalomyelitis/ meningoencephalitis/meningitis/ encepholapathy
  • Convulsions/seizures
  • Stroke
  • Narcolepsy and cataplexy
  • Anaphylaxis
  • Acute myocardial infarction (aka heart attack
  • Myocarditis/pericarditis
  • Autoimmune disease
  • Deaths
  • Pregnancy and birth outcomes
  • Other acute demyelinating diseases
  • Non-anaphylactic allergic reactions
  • Thrombocytopenia
  • Disseminated intravascular coagulation
  • Venous thromboembolism
  • Arthritis and arthralgia/joint pain
  • Kawasaki disease
  • Multi-system Inflammatory Syndrome in Children
  • Vaccine enhanced disease

While it’s clear that the list is not intended to detail definite negative outcomes of the COVID shot, it is clear that all of these conditions – including death – were and continue to be considered by the FDA and other experts as possible consequences of this unprecedented global jab experiment.

FDA documents reveal officials still on the lookout for jab-enhanced disease due to COVID jab, yet the mainstream media censors anyone raising concerns about this frightening phenomenon

Jab-enhanced disease, also known as antibody-dependent enhancement, is a particularly interesting item to see on the above FDA list, if only because the mainstream media and Big Tech giants have been quick to dismiss the idea that this could ever happen with the COVID shot.

As a reminder, jab-enhanced disease is a phenomenon in which people who have been fully vaxxed against a pathogen get infected with the pathogen anyway (which we know is happening with the COVID shot, thanks to so-called “breakthrough infections”) and experience an even worse disease course compared to people who are not vaxxed.

The COVID-19 crisis happening in the highly vaxxed country of Israel speaks to the possibility of this – something even the U.S. Centers for Disease Control and Prevention Director Rochelle Walensky acknowledged in an August 2021 press conference, when she said:  “We are watching other countries carefully and (are) concerned that we too will see what Israel is seeing, which is worsening infections over time [among vaccinated individuals.]”

Meanwhile, FDA officials acknowledged in a Vaccines and Related Biological Products Advisory Committee Meeting from December 10, 2020, that the Emergency Use Authorization request for the Pfizer and Moderna shots should “include strategies that will be implemented to ensure that ongoing clinical trials of the vaccine are able to assess long-term safety and efficacy (including evaluating for vaccine-associated enhanced respiratory disease and decreased effectiveness as immunity wanes over time).”

For the health and safety of the American public, let us hope such strategies are being implemented and upheld.

Sources for this article include:


Notify of

Newest Most Voted
Inline Feedbacks
View all comments